Mercer Global Advisors Inc Pulmonx Corp Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 82,095 shares of LUNG stock, worth $144,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,095
Previous 82,081
0.02%
Holding current value
$144,487
Previous $552,000
61.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LUNG
# of Institutions
115Shares Held
33.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA5.16MShares$9.09 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$6.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$4.04 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$3.33 Million0.11% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $65.6M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...